510(k) · Cleared
ClearedPacific Hemostasis Thromboscreen 200
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Pacific Hemostasis · KQG Instrument, Coagulation
Cleared on Jun 21, 1999 as substantially equivalent to K884863 (Medical Laboratory Automation Systems, Inc., 1989) and 1 other predicate after a 63-day review. Its family tree reaches back 1 generation to 1989.
- Decided
- Jun 21, 1999
- Review
- 63 days
- Class
- Class II
- Product code
- KQG
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to K884863 (1989). 2 ancestors in all. No later device cites it as a predicate yet.
- Root · 1 generation backK884863 Electra 900C Automatic Coagulation TimerMedical Laboratory Automation Systems, Inc. · 1989
- This deviceK991321 Pacific Hemostasis Thromboscreen 200Pacific Hemostasis · 1999
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K884863 | Electra 900C Automatic Coagulation Timer | Medical Laboratory Automation Systems, Inc. | 1989 | — |
| 0 (this device) | K991321 | Pacific Hemostasis Thromboscreen 200 | Pacific Hemostasis | 1999 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1989 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in KQG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K884863 | Electra 900C Automatic Coagulation TimerSummary page 1…boScreen® 200 Common Name: Manual Coagulation Instrument Classification Name: Instrument, Coagulation (per 21 CFR section 864.5400) Equivalent Devices: MLA-900C &1000C, #K884863, #K894052 Description of the ThromboScreeq" 200 sed-for the performance of in- vitro diagnostic clotting procedures in the cli… | 1989 |
| * | K894052 | Electra 1000C Automatic Coagulation TimerSummary page 1…200 Common Name: Manual Coagulation Instrument Classification Name: Instrument, Coagulation (per 21 CFR section 864.5400) Equivalent Devices: MLA-900C &1000C, #K884863, #K894052 Description of the ThromboScreeq" 200 sed-for the performance of in- vitro diagnostic clotting procedures in the clinical labo… | 1989 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- None of the 2 ancestors has a recall.
- 5 other devices also cite its predicate K884863.
How does its category compare?
All KQG devicesKQG Instrument, Coagulation: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · KQG
FDA has decided no KQG device since 2007.
Median 510(k) review, days · KQG
Too few KQG 510(k)s in any year since 2007 to give a median.
Recalls per year · KQG
1in 2010
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · KQG
16in 2010
MAUDE reports naming product code KQG, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 8 |
| 2010 | 0 | — | 1 | 16 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Pacific Hemostasis ThromboScreen® 200 is a photo-optical instrument used for the performance of in-vitro diagnostic coagulation testing in the clinical laboratory.
Coagulation testing capabilities of the device include routine clotting tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen (Clauss and Derived methods), as well as PT and APTT-based factor assays.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K991321 · printed Nov 4, 2026
Cite this page
510(k) Report. “K991321: Pacific Hemostasis Thromboscreen 200.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K991321
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026